Aristotle Capital Boston has disclosed a significant reduction in its stake in Huron Consulting Group (HURN), selling 40,351 shares valued at approximately $6.07 million as of May 15, 2026. This move reduces their position to 1.98% of the fund’s assets under management (AUM), with Huron shares down 30% over the past year, underperforming the S&P 500, which has gained about 25% during the same period.
Despite the sell-off, Aristotle still holds nearly $32 million in Huron shares, indicating a degree of ongoing confidence. Huron’s first-quarter revenue rose 12% year-over-year to a record $443.7 million, and the company reaffirmed its full-year guidance, driven primarily by strong demand in the healthcare sector. However, the firm faces challenges as its stock has dropped 39% this year, raising questions about its ability to maintain margin growth amid tightening corporate spending.
For market professionals, this transaction highlights the delicate balance between recognizing short-term stock performance issues and acknowledging strong operational fundamentals. Huron’s attractive revenue growth, combined with a lower valuation, may present a compelling opportunity for investors seeking value in a volatile market.
Source: fool.com